Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Abbott reports positive results of ABSORB Japan study comparing efficacy of fully dissolving heart stent to XIENCE

Abbott (NYSE: ABT) announced today positive one-year clinical results from ABSORB Japan, a multi-center, randomized trial comparing the safety and effectiveness of Abbott's fully dissolving Absorb™ heart stent to XIENCE ®, Abbott's market-leading, permanent drug eluting stent.

1 Sep 2015

Study: Inner-city neighbourhoods may affect risk of dying from cardiovascular disease

The inner-city neighbourhood in which someone lives may affect his or her risk of developing or dying from cardiovascular disease, a new research paper suggests.

1 Sep 2015

Carbonated beverage consumption associated with out-of-hospital cardiac arrests of cardiac origin

Carbonated beverages are associated with out-of-hospital cardiac arrests of cardiac origin, according to results from the All-Japan Utstein Registry presented for the first time today at ESC Congress.

1 Sep 2015

After acute myocardial infarction, respiratory infection associated with increased risk of mortality

Respiratory infection is associated with a four-fold increased risk of in-hospital cardiovascular mortality after acute myocardial infarction (AMI), according to research presented at ESC Congress today by Dr Catarina Quina-Rodrigues, a cardiologist at Hospital de Braga in Portugal. The findings highlight the importance of diagnostic alertness for respiratory infections in AMI patients so that therapeutic measures can be promptly taken.

31 Aug 2015

Resverlogix presents new data on RVX-208 orally active BET inhibitor at ESC Congress 2015

Resverlogix Corp. is pleased to announce that Dr. Norman Wong, chief scientific officer of Resverlogix Corp. presented new data at the European Society of Cardiology (ESC) Congress 2015 in a poster presentation titled: "RVX-208, an orally active BET inhibitor, lowers CVD risk by activities beyond raising ApoA-I/HDL."

31 Aug 2015

Study: Depressed patients three times more likely to experience frequent chest pain

Depressed patients have more frequent chest pain even in the absence of coronary artery disease, according to results from the Emory Cardiovascular Biobank presented at ESC Congress today by Dr Salim Hayek, a cardiologist at Emory University School of Medicine in Atlanta, Georgia, US.

31 Aug 2015

LCZ696 reduces aortic systolic blood pressure, pulse pressure in hypertensive patients

The combination drug valsartan/sacubitril known as LCZ696 significantly reduced aortic systolic blood pressure and pulse pressure compared to the standard angiotensin receptor blocker (ARB) olmesartan in patients with hypertension, according to results of the PARAMETER study.

31 Aug 2015

Patients with suggestive AMI can be triaged more quickly and safely using rapid, sensitive assay

Patients arriving at the emergency department with chest pain suggestive of acute myocardial infarction (AMI) can be triaged more quickly and more safely using a new rapid assay with refined cut-offs, German research suggests.

31 Aug 2015

TECOS analysis shows sitagliptin safe and effective in patients with type-2 diabetes, cardiovascular disease

Patients with type-2 diabetes and cardiovascular disease can safely take the antihyperglycemic drug sitagliptin without an increased risk of cardiovascular complications - even if they have a history of heart failure - a new analysis of the TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin) study shows.

31 Aug 2015

ELIXA trial results demonstrate cardiovascular safety of lixisenatide drug

In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the Evaluation of Lixisenatide in Acute Coronary Syndrome (ELIXA) trial.

31 Aug 2015

ATTEMPT-CVD trial results show that ARBs may have better impact on CVD biomarkers

When it comes to treating high blood pressure, not all anti-hypertensive medications are equal, and results of the ATTEMPT-CVD trial suggest that telmisartan, an angiotensin II receptor blocker (ARB) might have benefits over non-ARB treatment.

31 Aug 2015

Robert Wood Johnson Medical Group physicians selected for Best Doctors in America List for 2015-2016

Sixty-one physicians affiliated with Robert Wood Johnson Medical Group, the faculty practice of Rutgers Robert Wood Johnson Medical School, were selected for the Best Doctors in America® List for 2015-2016. Only 5 percent of physicians in the United States earn this prestigious honor, determined by impartial peer review.

29 Aug 2015

Many primary care physicians overestimate their ability to assess Ebola risks in patients

While most primary care physicians responding to a survey taken in late 2014 and early 2015 expressed confidence in their ability to identify potential cases of Ebola and communicate Ebola risks to their patients, only 50 to 70 percent of them gave answers that fit with CDC guidelines when asked how they would care for hypothetical patients who might have been exposed to Ebola.

28 Aug 2015

Air and noise pollution has severe consequences on heart health

Cardiovascular diseases (CVD), including heart disease and stroke, are the no 1 killer worldwide and in Europe, where they cause the death of over 10 000 people daily, i.e. more than all cancers combined.

28 Aug 2015

Philips to showcase latest cardiology solutions at ESC Congress 2015

Royal Philips today announced its presence at ESC Congress 2015, where the company is showcasing its latest cardiology solutions, including Heart ModelA.I., EchoNavigator and IntelliSpace Cardiovascular, that connect people and technology with care protocols to assist diagnosis, guide treatment and enable home care.

28 Aug 2015

Melatonin hormone can help prevent cardiovascular disease risk in children born through ART

Studies are revealing that children born through assisted reproductive technologies (ART) have a higher risk of developing cardiovascular disease. The increased risk is due to changes in the expression of the genes important for vascular health. These studies suggest that the composition of the solutions in which embryo fertilization and culturing are done is to blame.

28 Aug 2015

School meals become more nutritious

The amount of whole grains and fresh fruits and vegetables offered in school meals is up and sodium is down, according to a Centers for Disease Control and Prevention report released Thursday.

27 Aug 2015

People who eat high protein foods have lower blood pressure and arterial stiffness

Eating foods rich in amino acids could be as good for your heart as stopping smoking or getting more exercise - according to new research from the University of East Anglia.

27 Aug 2015

Global life expectancy climbs, but people live longer with illnesses

Global life expectancy has risen by more than six years since 1990 as healthy life expectancy grows; ischemic heart disease, lower respiratory infections, and stroke cause the most health loss around the world.

27 Aug 2015

Rehabilitation can improve prognosis for heart disease, reduce patient mortality

Rehabilitation is recommended for many patients following a hospital stay for acute heart disease. In a recent original article in Deutsches Ärzteblatt International (Dtsch Arztebl int 112: 527-34) Axel Schlitt et al. show that this improves prognosis for heart disease and can thus reduce patient mortality.

27 Aug 2015

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Abbott reports positive results of ABSORB Japan study comparing efficacy of fully dissolving heart stent to XIENCE

Study: Inner-city neighbourhoods may affect risk of dying from cardiovascular disease

Carbonated beverage consumption associated with out-of-hospital cardiac arrests of cardiac origin

After acute myocardial infarction, respiratory infection associated with increased risk of mortality

Resverlogix presents new data on RVX-208 orally active BET inhibitor at ESC Congress 2015

Study: Depressed patients three times more likely to experience frequent chest pain

LCZ696 reduces aortic systolic blood pressure, pulse pressure in hypertensive patients

Patients with suggestive AMI can be triaged more quickly and safely using rapid, sensitive assay

TECOS analysis shows sitagliptin safe and effective in patients with type-2 diabetes, cardiovascular disease

ELIXA trial results demonstrate cardiovascular safety of lixisenatide drug

ATTEMPT-CVD trial results show that ARBs may have better impact on CVD biomarkers

Robert Wood Johnson Medical Group physicians selected for Best Doctors in America List for 2015-2016

Many primary care physicians overestimate their ability to assess Ebola risks in patients

Air and noise pollution has severe consequences on heart health

Philips to showcase latest cardiology solutions at ESC Congress 2015

Melatonin hormone can help prevent cardiovascular disease risk in children born through ART

School meals become more nutritious

People who eat high protein foods have lower blood pressure and arterial stiffness

Global life expectancy climbs, but people live longer with illnesses

Rehabilitation can improve prognosis for heart disease, reduce patient mortality

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in